DETAILING STORY FUTURE- DAY 1

© Mankind Pharma 2020, All rights reserved.

COMPANY INTRODUCTION Nurokind Morning Sir, PAGE 1
I am ……………………………… from Future Mankind, a Mankind
© Mank©inMd aPnhkairnmdaP2h0a2rm0,aA2ll0r2ig0h, tAsllrerisgehrtvserde.served. Group of Company.
• Sir Mankind feels great pleasure to inform you that we

have started Operations in USA with Office in New Jersey.
• Sir, supported by 18000 employees and medical

fraternity with 21 manufacturing units, Mankind is Rank
No.1 as per P/D/M. However, value wise the rank is 4th,
this clearly shows that Mankind product range is
affordable.
• Sir, Mankind has built world-class R & D center at
Manesar - NCR; backed by 350 experienced scientists.
The focus areas of research are:
API development: Sir, we feel proud to share that we are
the 1st company in India and 2nd in the world to develop
Dydrogesterone API.
• Sir, I feel proud to share the opening of 21st
Manufacturing unit and recently one of our
manufacturing unit III has received USFDA approval
• Sir, for last 24 years we at Mankind is bringing medicines
at very affordable prices.
• Sir, we need your blessings and support for Future
Mankind as well.

© Mankind Pharma 2020, All rights reserved.

© Mankind Pharma 2020, All rights reserved.